Related Experiment Video
Updated: Dec 7, 2025
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.6K
Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient Outcomes
Boris A Hadaschik1, Frederik L Giesel2, Kim Chi3
1Department of Urology, University of Duisburg-Essen and German Cancer Consortium, University Hospital Essen, Essen, Germany.
European Urology Focus
|September 25, 2020
Summary
Prostate-specific membrane antigen (PSMA) PET/CT imaging improves prostate cancer staging. PSMA radioligand therapy shows promise for advanced prostate cancer patients, offering new hope for treatment.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiochemistry
Background:
- Advanced imaging techniques are crucial for refining clinical care and patient outcomes.
- Prostate-specific membrane antigen (PSMA) PET/CT has become a vital tool in oncology.
- Accurate staging is essential for effective prostate cancer management.
Purpose of the Study:
- To highlight the role of PSMA PET/CT in improving prostate cancer staging.
- To discuss the potential of PSMA radioligand therapy in treating metastatic prostate cancer.
Main Methods:
- Review of current literature on PSMA PET/CT imaging.
- Analysis of clinical data regarding PSMA radioligand therapy efficacy.
Main Results:
- PSMA PET/CT enables more precise staging of prostate cancer compared to conventional methods.
- PSMA radioligand therapy has shown significant promise in patients with metastatic castration-resistant prostate cancer who have undergone extensive prior treatments.
Conclusions:
- PSMA PET/CT represents a significant advancement in prostate cancer diagnostics.
- PSMA radioligand therapy offers a new therapeutic avenue for refractory metastatic prostate cancer.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
358
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
358
01:29Positron Emission Tomography
6.7K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.7K